Journal
CURRENT DERMATOLOGY REPORTS
Volume 1, Issue 1, Pages 29-38Publisher
SPRINGER
DOI: 10.1007/s13671-011-0003-5
Keywords
Comorbidity; Atopic dermatitis; Epicutaneous; sensitization; Skin barrier; Eczema; Asthma; Attentiondeficit-hyperactivity-disorder; Eczema; Food allergy; Cancer; Depression; Autism
Categories
Funding
- National Institutes of Health [5K23AR057486-02]
Ask authors/readers for more resources
The negative impact of atopic dermatitis (AD) often extends beyond the skin. Children with AD experience increased rates of infectious, mental health, and allergic diseases compared to their non-atopic peers. The mechanisms underlying these associations remain elusive. New insights from genetic and epidermal research pinpoint the skin barrier as a primary initiator of AD. Epicutaneous sensitization represents an intriguing new model that links a disrupted skin barrier to the later development of IgE-mediated diseases in patients with AD. Recent epidemiologic studies have identified new comorbidities linked to AD as well, including several mental health disorders and obesity. This article reviews the recent literature regarding both classic and newly described AD comorbidities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available